Blog
Big Molecule Watch
November 3, 2020
Election Day in the US
In observance of Election Day, Goodwin’s US offices are closed on Tuesday, November 3. We encourage everyone in our community to do their civic duty and vote. The BMW blog will be back on Wednesday, November 4.
The post Election Day in the US appeared first on Big Molecule Watch.
Related Content
- Big Molecule WatchNovember 6, 2026
Theriva Biologics Sells Antibiotic-Degrading Enzyme Portfolio to Biossil Labs
- Big Molecule WatchNovember 6, 2026
Adalvo Expands Biosimilars Portfolio Through Acquisition of Romiplostim Biosimilar Program from Enzene
- Big Molecule WatchNovember 6, 2026
FDA Approves Xbrane’s LUCAMZI™, a Biosimilar to LUCENTIS®
- Big Molecule WatchNovember 3, 2026
Global Biosimilar Market Update: Secukinumab Biosimilar Approval in China and Expanded Ustekinumab Licensing Rights
- Big Molecule WatchOctober 30, 2026
Armed Cell Therapeutics Acquires Preclinical CAR-T Portfolio from Lakefront
- Big Molecule WatchOctober 23, 2026
European Commission Makes Sanofi’s Antitrust Commitments Binding
- Big Molecule WatchOctober 21, 2026
Alvotech and Advanz Pharma Announce Submission for Proposed Eylea 8 mg Biosimilar
- Big Molecule WatchOctober 21, 2026
FDA Accepts Formycon and Zydus’ Proposed Pembrolizumab Biosimilar for Review
- Market RecognitionOctober 3, 2025
Goodwin Named an LMG Life Sciences Life Cycle Firm for the Fourteenth Consecutive Year
- Market RecognitionSeptember 9, 2024
Goodwin Named Venture Capital Firm of the Year, Hatch-Waxman Litigation Firm of the Year and Life Cycle Firm of the Year at the 2024 LMG Life Sciences Americas Awards
- Market RecognitionSeptember 25, 2023
Goodwin Named an LMG Life Sciences Life Cycle Firm for the Twelfth Consecutive Year
- Market RecognitionOctober 4, 2022
LMG Recognizes Goodwin Lawyers and Practices for Excellence in Life Sciences
- Press ReleaseNovember 17, 2021
Goodwin Releases Update to its Comprehensive Guide to Biosimilars Litigation and Regulation in the U.S.
- Market RecognitionOctober 26, 2021
Goodwin Named an LMG Life Sciences Life Cycle Firm for the Tenth Consecutive Year
- Press ReleaseJune 28, 2021
Goodwin Adds Life Sciences and Healthcare Litigation Partner William Jackson
- EventsDecember 5, 2020
China's Patent Linkage System: Can Strategies that Work in the U.S. System Be Applied to China?